India Exchange Filings

Divi’s Laboratories Q2 FY27 Earnings and Board Meeting Highlights

Divi’s Laboratories Ltd reports Q2 FY27 consolidated revenue of ₹3,676 crore, up 35.4% year on year

  • Net profit was ₹1,127 crore, up 63.6% year on year and 24.9% sequentially.
  • Operating margin was 38.7%; revenue rose 19.4% sequentially.
  • No exceptional items were reported; statutory auditors issued unmodified limited-review reports.

Original Filing

This is an automated summary of a public document. Always check the original before relying on it.